BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21466441)

  • 1. Bv8-prokineticins and their receptors: modulators of pain.
    Negri L; Lattanzi R
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1720-7. PubMed ID: 21466441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bv8/PK2 and prokineticin receptors: a druggable pronociceptive system.
    Negri L; Lattanzi R
    Curr Opin Pharmacol; 2012 Feb; 12(1):62-6. PubMed ID: 22136937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bv8/Prokineticins and their Receptors A New Pronociceptive System.
    Negri L; Lattanzi R; Giannini E; Canestrelli M; Nicotra A; Melchiorri P
    Int Rev Neurobiol; 2009; 85():145-57. PubMed ID: 19607967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior.
    Negri L; Lattanzi R; Giannini E; Colucci M; Margheriti F; Melchiorri P; Vellani V; Tian H; De Felice M; Porreca F
    J Neurosci; 2006 Jun; 26(25):6716-27. PubMed ID: 16793879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulators of pain: Bv8 and prokineticins.
    Negri L; Lattanzi R; Giannini E; Melchiorri P
    Curr Neuropharmacol; 2006 Jul; 4(3):207-15. PubMed ID: 18615143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of transient receptor potential vanilloid 1 by the prokineticin receptor agonist Bv8.
    Vellani V; Colucci M; Lattanzi R; Giannini E; Negri L; Melchiorri P; McNaughton PA
    J Neurosci; 2006 May; 26(19):5109-16. PubMed ID: 16687502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bv8/Prokineticin proteins and their receptors.
    Negri L; Lattanzi R; Giannini E; Melchiorri P
    Life Sci; 2007 Sep; 81(14):1103-16. PubMed ID: 17881008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain.
    Giannini E; Lattanzi R; Nicotra A; Campese AF; Grazioli P; Screpanti I; Balboni G; Salvadori S; Sacerdote P; Negri L
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14646-51. PubMed ID: 19667192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prokineticin system: an interface between neural inflammation and pain.
    Franchi S; Sacerdote P; Panerai A
    Neurol Sci; 2017 May; 38(Suppl 1):27-30. PubMed ID: 28527062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent Angiogenesis.
    Negri L; Ferrara N
    Physiol Rev; 2018 Apr; 98(2):1055-1082. PubMed ID: 29537336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptor.
    Lattanzi R; Maftei D; Negri L; Fusco I; Miele R
    Neuropeptides; 2018 Oct; 71():32-42. PubMed ID: 30253862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal Pain Sensation in Mice Lacking the Prokineticin Receptor PKR2: Interaction of PKR2 with Transient Receptor Potential TRPV1 and TRPA1.
    Maftei D; Vellani V; Artico M; Giacomoni C; Severini C; Lattanzi R
    Neuroscience; 2020 Feb; 427():16-28. PubMed ID: 31883821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1.
    Chen J; Kuei C; Sutton S; Wilson S; Yu J; Kamme F; Mazur C; Lovenberg T; Liu C
    Mol Pharmacol; 2005 Jun; 67(6):2070-6. PubMed ID: 15772293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and regulation of the prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) and their receptors in the human endometrium across the menstrual cycle.
    Battersby S; Critchley HO; Morgan K; Millar RP; Jabbour HN
    J Clin Endocrinol Metab; 2004 May; 89(5):2463-9. PubMed ID: 15126578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Prokineticin System to Control Chronic Pain and Inflammation.
    Negri L; Maftei D
    Curr Med Chem; 2018; 25(32):3883-3894. PubMed ID: 28707588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological activity of a Bv8 analogue modified in position 24.
    Lattanzi R; Sacerdote P; Franchi S; Canestrelli M; Miele R; Barra D; Visentin S; DeNuccio C; Porreca F; De Felice M; Guida F; Luongo L; de Novellis V; Maione S; Negri L
    Br J Pharmacol; 2012 Jun; 166(3):950-63. PubMed ID: 22122547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of amygdala prokineticin receptor 2 neurons drives the anorexigenic activity of the neuropeptide PK2.
    Yin TC; Mittal A; Buscaglia P; Li W; Sebag JA
    J Biol Chem; 2023 Jan; 299(1):102814. PubMed ID: 36539034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prokineticin receptor 1 (PKR1) signalling in cardiovascular and kidney functions.
    Boulberdaa M; Urayama K; Nebigil CG
    Cardiovasc Res; 2011 Nov; 92(2):191-8. PubMed ID: 21856786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and regulation of bv8 in human blood cells.
    Zhong C; Qu X; Tan M; Meng YG; Ferrara N
    Clin Cancer Res; 2009 Apr; 15(8):2675-84. PubMed ID: 19336519
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.